UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Use of vemurafenib in anaplastic thyroid carcinoma: a case report

Cancer biology & therapy, 2015-10, Vol.16 (10), p.1430-1433

2015

Volltextzugriff (PDF)

Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review

International journal of urology, 2014-07, Vol.21 (7), p.630-637

2014

Volltextzugriff (PDF)

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003427

2022

Volltextzugriff (PDF)

Is Oncotype DX test necessary for T1b grade 1, hormone receptor positive HER-2 negative breast cancer? A single institution retrospective analysis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12598-e12598

Gudena, Vinay K.

2018

Volltextzugriff (PDF)

A pharmacogenetic analysis of peripheral sensory neuropathy related to administration of taxanes in breast cancer patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13133-e13133

2019

Volltextzugriff (PDF)

258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A281-A282

2020

Volltextzugriff (PDF)

Performance of Oncotype Dx test in patients with T1bN0, grade 1, hormone receptor-positive, HER2-negative breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12043-e12043

2019

Volltextzugriff (PDF)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Therapeutics and clinical risk management, 2008-12, Vol.4 (6), p.1157-1164

2008

Volltextzugriff (PDF)

Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review

Cancer biology & therapy, 2008-06, Vol.7 (6), p.810-813

2008

Volltextzugriff (PDF)

Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12003-12003

2023

Volltextzugriff (PDF)

Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the wake forest nCI community oncology research program (NCORP) research base REMEMBER trial (WF97116)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12076-12076

2023

Volltextzugriff (PDF)

Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy

Seminars in oncology nursing, 2023-08, Vol.39 (4), p.151445-151445, Article 151445

2023

Volltextzugriff (PDF)

Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12024-12024

2022

Volltextzugriff (PDF)

Activity of tesetaxel, an oral taxane, given as a single-agent in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) in a phase 2 study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1042-1042

2018

Volltextzugriff (PDF)

Randomized trial of atorvastatin during and following receipt of doxorubicin for breast cancer and lymphoma (WF-98213)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12072-12072

2022

Volltextzugriff (PDF)

Phase II Study of Dasatinib (BMS‐354825) in Patients With Metastatic Adenocarcinoma of the Pancreas

The oncologist (Dayton, Ohio), 2013-10, Vol.18 (10), p.1091-1092

2013

Volltextzugriff (PDF)

LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS1125-TPS1125

2017

Volltextzugriff (PDF)

A Phase II Study of Gemcitabine and Irinotecan in Patients With Locally Advanced or Metastatic Bladder Cancer

American journal of clinical oncology, 2014-04, Vol.37 (2), p.188-193

2014

Volltextzugriff (PDF)

Abstract PD8-06: Incidence of Acute and Persistent Clinically Meaningful Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD8-06-PD8-06

2023

Volltextzugriff (PDF)

Testicular Lymphoma: An Update for Clinicians

The American journal of the medical sciences, 2008-10, Vol.336 (4), p.336-341

2008

Volltextzugriff (PDF)

A Case of platelet storage pool deficiency of dense granules (Delta SPD)

The American journal of case reports, 2011, Vol.12, p.23-26

2011

Volltextzugriff (PDF)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Therapeutics and clinical risk management, 2008-10, Vol.2008 (Issue 6), p.1157-1164

2008

Volltextzugriff (PDF)

Microangiopathic Hemolytic Anemia (MHA) Associated with Acute Rheumatic Valvulitis

Blood, 2004-11, Vol.104 (11), p.3679-3679

2004

Volltextzugriff (PDF)

Primary Testicular Lymphoma and AIDS

Annals of clinical and laboratory science, 2010, Vol.40 (1), p.75-79

2010

Volltextzugriff (PDF)

AN UNUSUAL CASE OF SQUAMOUS CELL ESOPHAGEAL CARCINOMA IN A 34 YEAR OLD MALE: ROLE OF SCREENING?

The American journal of gastroenterology, 2004-10, Vol.99, p.S161

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)
Berichte
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(8)
Oncology
(6)
Chemotherapy
(4)
Male
(4)
Middle Aged
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biological And Medical Sciences
(3)
Breast Cancer
(3)
Cancer
(3)
Female
(3)
Immunotherapy
(3)
Medical Sciences
(3)
Metastasis
(3)
Adult
(2)
Aged
(2)
Aged, 80 And Over
(2)
Anaplastic Thyroid Cancer, Braf Inhibitors, Vemurafenib
(2)
Cancer Therapies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of vemurafenib in anaplastic thyroid carcinoma: a case report

Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Is Oncotype DX test necessary for T1b grade 1, hormone receptor positive HER-2 negative breast cancer? A single institution retrospective analysis

A pharmacogenetic analysis of peripheral sensory neuropathy related to administration of taxanes in breast cancer patients

258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Performance of Oncotype Dx test in patients with T1bN0, grade 1, hormone receptor-positive, HER2-negative breast cancer

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review

Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714

Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the wake forest nCI community oncology research program (NCORP) research base REMEMBER trial (WF97116)

Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy

Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481)

Activity of tesetaxel, an oral taxane, given as a single-agent in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) in a phase 2 study

Randomized trial of atorvastatin during and following receipt of doxorubicin for breast cancer and lymphoma (WF-98213)

Phase II Study of Dasatinib (BMS‐354825) in Patients With Metastatic Adenocarcinoma of the Pancreas

LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC)

A Phase II Study of Gemcitabine and Irinotecan in Patients With Locally Advanced or Metastatic Bladder Cancer

Abstract PD8-06: Incidence of Acute and Persistent Clinically Meaningful Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)

Testicular Lymphoma: An Update for Clinicians

A Case of platelet storage pool deficiency of dense granules (Delta SPD)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review

Microangiopathic Hemolytic Anemia (MHA) Associated with Acute Rheumatic Valvulitis

Primary Testicular Lymphoma and AIDS

AN UNUSUAL CASE OF SQUAMOUS CELL ESOPHAGEAL CARCINOMA IN A 34 YEAR OLD MALE: ROLE OF SCREENING?

Suchergebnisse filtern